Cameron Leads International Mesothelioma Symposium on Lung-Sparing Therapies

Renowned thoracic surgeon Robert Cameron, M.D., has spent much of the last two decades convincing the medical community that leaving both lungs intact is the best way to treat patients with pleural mesothelioma. Slowly, but surely, he has prevailed. Cameron, chief of thoracic surgery at the West Los Angeles VA Medical Center and director of the UCLA Mesothelioma Program, has converted many with his efforts, turning the pleurectomy/decortication (P/D) surgery he has pioneered into the standard of surgical care. Cameron will be at his persuasive best on June 7 as the featured speaker at the 4th International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma. UCLA and the Pacific Meso Center will co-host the event in Santa Monica, Calif. The day-long symposium is geared toward pulmonary physicians, oncologists and other medical professionals, but it also is open to mesothelioma patients, families and advocates looking for the most up-to-date treatment advances. Latest Research and Advancements There will be sessions on the latest mesothelioma research involving mesenchymal stem cells, the role of genes and molecular mechanisms, intraoperative betadine lavage therapy, postoperative tomotherapy and adjuvant chemotherapy. Sessions include the Role of Adjuvant Pain Therapy, Intrathecal Drug Delivery and Spinal Cord Stimulators, along with Pleural Mesothelioma: Implications for Surgical Technique and Adjuvant Therapies. There is a session on Mesothelioma ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Tags: Research & Clinical Trials Source Type: news